Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - SHORT-TERM DEBT
Short-term Debt ENTA - Enanta Pharmaceuticals, Inc.
3.05 M
LAST VALUE
-27.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR